Evidence map›Paper›PMID 34204126›Full record

ReviewInternational journal of environmental research and public health2021

Quality of Life in Hidradenitis Suppurativa: An Update.

Pavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, Francoise Poot, Francesca Sampogna, Servando E Marron, Sergey V Zemskov, Damiano Abeni, Thrasyvoulos Tzellos, Jacek C Szepietowski and 1 more

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Pooled it
  2. Australasian hidradenitis suppurativa management guidelines.The Australasian journal of dermatology · 2025
    Guideline
  3. Review
  4. Family quality-of-life burden in chronic spontaneous urticaria: A multicentre study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  5. Skin health and disease · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Management of penoscrotal hidradenitis: a narrative review.International journal of impotence research · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pavel V ChernyshovDepartment of Dermatology and Venereology, Bogomolets National Medical University, 01601 Kiev, Ukraine.ORCID 0000-0001-7275-4651
Andrew Y FinlayDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.ORCID 0000-0003-2143-1646
Lucia Tomas-AragonesDepartment of Psychology, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0001-5891-628X
Francoise PootDepartment of Dermatology, University Hospital Erasme, 1070 Brussels, Belgium.
Francesca SampognaClinical Epidemiology Unit, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-7624-3290
Servando E MarronAragon Psychodermatology Research Group (GAI + PD), Department of Dermatology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.ORCID 0000-0001-5632-0351
Sergey V ZemskovDepartment of General Surgery, Bogomolets National Medical University, 01601 Kiev, Ukraine.ORCID 0000-0002-5039-1324
Damiano AbeniClinical Epidemiology Unit, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-0167-7617
Thrasyvoulos TzellosDepartment of Dermatology, NLSH University Hospital, 8092 Bodø, Norway.
Jacek C SzepietowskiEuropean Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.ORCID 0000-0003-0766-6342
Christos C ZouboulisEuropean Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge on hidradenitis suppurativa/acne inversa (HS) is rapidly increasing. HS has a profound impact on patients and their family life. Several factors, such as comorbidities, unemployment and HS severity, make this impact even more severe. The most widely used instrument to measure this impact is the dermatology-specific DLQI. We also identified six HS-specific health-related quality of life (HRQoL) instruments. Of them, HIDRAdisk, HSIA, HiSQOL and HSQoL-24 are better validated but there is still lack of experience of its use. Several treatment methods showed positive effect on patients' HRQoL. Surgery remains a method with a substantial positive effect on HRQoL. Several studies confirming a positive effect of adalimumab on the HRQoL of patients with HS were published during the last three years. Data on the influence of several other biologics on HRQoL of HS patients are controversial or based on studies with a small number of patients.

Indexed as

Biological ProductsHidradenitis SuppurativaHumansQuality of LifeResearch DesignSeverity of Illness IndexUnemploymentBiological Productsbiologicshidradenitis suppurativaimpactquality of lifesurgerytreatment

Identifiers

PMID34204126
PMCPMC8201351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.